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Pemphigus is a disease involving human stratified squamous 
epithelial tissues which is characterized histologically by th e 
presence of intraepidermal blisters. These form above the basal 
cell layer in pemphigus vulgaris and vegetans or through the 
granular or upper malpighian layers in pemphigus erythema-
tosis and pemphigus foliaceous (including Brazilian pemphigus 
or " fogo selvagem"). The most distinguishing histologic featw-e 
of the pemphigus lesion is the distinctive acantholytic cell , 
which is a physically separated epidermal cell containing a 
small pyknotic nucleus surrounded by a clear zone or "halo," 
an intensely eosinophilic cytoplasm and rounded borders [1]. 
Diverse mechanisms have been proposed to explain the lesions 
of pemphigus. Prominent theories have included bacterial and 
viral infections, electrolytic imbalances resulting from disturbed 
adrenocortical function, serum toxicity, and tissue and serum 
h ydrolytic enzymes. Many of these notions have not sw-vived 
critical experimental protocols and some concepts involving 
systemic or metabolic disorders have been shown to be second-
ary consequences of the disease. 
The discovery was made in 1964 that pemphigus patients 
have serum antibodies which bind to stratified squamous epi-
thelial cells [2,3]. Since these antibodies were unique to pem-
phigus patients, were bound at the site of the lesion and the 
antibody titers correlated with disease activity [ 4], it was a 
reasonable hypothesis that the antibodies were responsible for 
producing the lesion. Direct experimental evidence for this 
hypothesis, however, was not presented until1972 when Wood, 
B eutner, and Chorzelski [5] and Holubar et al [6] respectively 
demonstrated that pemphigus antibody bound and acantholysis 
occw-red in monkey skin or oral epithelia following local injec-
tion of pemphigus serum. These animal experiments were re-
garded with caution, however , because the repeated injections 
which were required to produce acantholysis caused consider-
able tissue trauma. In addition, it could not be demonstrated 
that the pemphigus antibody was capable of fixing complement 
in indirect immunofluorescent tests [7,8] and precedent did not 
exist whereby an antibody could induce tissue damage without 
participation of complement and inflammatory cells. 
In 1974, Michel and Ko [9,10] introduced a new approach to 
studying pemphigus by their demonstration that epidermal 
acantholysis occw-red in normal human skin explants cultured 
in vitro with whole pemphigus serum. Although Bellone and 
Leone had reported in vitro experiments in 1956 which yielded 
similar results [ll], the work was not well publicized and the 
significance of theix observations were overlooked. Schiltz and 
Michel [12] later showed that it was t he IgG fraction which 
caused the in vitro "lesion" and that complement was not 
required. Similar observations have since been made by others 
using human [13] or monkey skin.[14,15] and the ultrastructural 
changes which occw- in vitro are similar to those which occur 
in vivo [16,17]. 
Ow· work will be reviewed which deals with the interaction 
of the pemphigus antibody with human epidermal cells cultured 
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in vitro as skin explants, intact epidermis or cell suspensions. 
From these studies a concept for pemphigus acantholysis has 
been developed whereby the living epidermal cell, without 
participation of complement, responds to the pemphigus anti-
body by generation of an active "pemphigus acantholysis fac-
tor" (PAF). PAF appears to be a proteolytic enzyme which 
originates from the epidermal cell and causes th e characteristic 
lesion of the disease. A sin1ilar concept has been advanced by 
Farb, D ykes, and Lazarus [18]. Addition of pemphigus serum 
to monolayer cultures of mouse epidermal cells resulted in 
antibody binding and reduced cellulru· adherence to the culture 
vessel. Because the process was prevented by serine protease 
inhibitors, t hey postulated that loss of adhesion and pemphigus 
acantholysis was caused by an epidermal serine protease. 
The techniques used to prepru·e human skin for explant [12] 
or cell suspension cultw-e [20] have been described. The skin is 
usually obtained from nonpemphigus patients undergoing rad-
ical mastectomy. For explan t cult ure on floating lens paper 
rafts, the medium consists of Ham's F-10 to which has been 
added 10% heat-denatured fetal calf serum and IgG fractions 
from human AB serum (controls) or pemphigus serum. For cell 
suspension cultw-es, fetal calf serum was omitted and a 3H-
amino acid mixture was added to assess protein synthesis. All 
incubations were at 37°C in a humid atmosphere containing 5% 
C02/95% air. 
SKIN EXPLANT STUDIES 
Dming a 5-day period normal human skin explants cultured 
with pemphigus lgG underwent characteristic histological 
changes. After 1 day extracellular spaces developed between 
keratinocytes which were shown by electron microscopy to be 
caused by dissolu tion of the cell sw-face glycocalyx in nondes-
mosomal areas [16]. After 3 days extensive suprabasilar acan-
tholysis occurred which was indistinguishable fi-om that seen in 
patient's lesions (Fig 1B). In mru·ked contrast, skin cultured 3 
days with normal IgG displayed histological featm es chru·acter-
istic of explant cultures, including intercellulru· edema, para-
keratosis and epiboly, but acantholysis did not occur (Fig lA). 
The extent and time of onset of acantholysis was dependent 
upon the antiepithelial an tibody titer, and acanth olysis did not 
occur at titers less than 80. Furthermore, since the in vitro 
" lesions" resembled that seen in pemphigus vulgaris biopsies, 
even when th e IgG source was from patients with pemphigus 
foliaceous or fogo selvagem, it may be t hat patients with differ-
en t forms of the disease respond differently to a similru· autoan-
tibody. Autoradiographic studies demonstrated that in the pres-
ence of the autoant ibody the capacity for the suprabasila1· 
"tru·get cells" to accumulate RNA and proteins was reduced 
with respect to that of basal cells and no accumulation of these 
macromolecules occw-red in the definitive acantholytic cell. 
Experiments were performed to determine if complement 
was required for acantholysis to occw· in vitro. When the 
medium containing pemphigus IgG was heated at 58°C for l 
hr, acantholytic activity remained. When pemphigus lgG was 
digested with papain under controlled conditions so that the Fe 
portion of the molecule (which binds C3) was removed, t he 
resulting univalent Fab fragments produced acantholysis in 
cultmed skin . These experiments provide strong evidence that 
complement is not involved in the primary mechanism of 
acantholysis. 
Explant cultures were employed to test selected compounds 
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for ability to prevent pemphigus IgG binding to the epidermis 
and acantholysis [19]. At therapeutic concentrations, hydrocor-
tisone and triamcinolone acetonide (both at 10- 5 M) did not 
prevent IgG binding to the epidermis or acantholysis. Similarly, 
th e t hioglucose salt of gold (10- 5 M) or soybean trypsin inhibitor 
(100 llg/ ml) , which is a serine protease inhibitor, did not prevent 
binding or acantholysis. These experiments support the con-
cepts that t he th erapeutic effectiveness of steroids and gold 
salts is pro.bably due to their demonstrated ability to reduce 
serum autoantibody titers and that pemphigus acantholysis is 
probably not caused by a serine protease. 
EPIDERMAL CELL SUSPENSION STUDIES 
Although new general insights about pemphigus acantholysis 
had been gained using explant-cultured skin, that system had 
limited utility for more detailed biochemical studies of the 
mechanism. We th erefore studied effects of the pemphigus 
antibody on aspects of protein metabolism by freshly-prepared 
human epidermal cells in short-term suspension culture [20]. 
These studies have provided evidence that pemphigus acantho-
lysis is caused by autoantibody-induced synthesis or release of 
an epidermal protease(s). 
Nearly 70% of epidermal cells prepared by trypsinization 
retained the capacity to bind pemphigus antibody to their 
surface (immunofluorescence) , and during 18-hr incubation pe-
riods 75% of th ese cells were killed as compared to 14% in 
control medium containing normal IgG. When 3H-amino acids 
were included in the medium to assess protein synthesis during 
this period, accumulation of radioactive proteins was inhibited 
about 57% by pemphigus IgG, relative to the normal IgG 
controls. Kinetic studies sh owed that this inhibition was anti-
body concentration-dependent and time-dependent. Inhibit ion 
did not occur at pemphigus ant ibody titers less than 50 and 
began after 2 hr. A cell fractionation scheme was devised to 
study the partitioning of the newly-synthesized proteins into 
(i) the medium, (ii) the water-soluble cellular fraction, and (iii) 
FIG l. Photomicrographs of normal human skin explants which had 
been cultured 72 hr in F -10 medium containing 32 mg/ ml normal 
human lgG (A) or pemphigus l gG (B) , the latter at an antiepithelial 
antibody t iter = 320. hematoxylin & eosin, X 180. 
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FIG 2. Effects of normal or pemphigus lgG on the accumulation of 
radioactive insoluble cellular proteins by suspensions of human epider-
mal cells. Cell suspension cultures (2.1 x lOu cells in 0.6 ml F-10 
medium) were incubated with 11.4 mg/ ml normal or pemphigus IgG 
(antiepithelia l antibody titer = 150) + 5 /lCi per culture 3H-amino acid 
mixture. At the indicated times the cellular-insoluble fraction was 
prepared (reference 20) and the radioactivity determined. 
the water-insoluble cellular fraction. Pemphigus IgG caused a 
concentration-dependent shift from the insoluble fraction to 
the medium. During the first 2 hr of culture, accumulation into 
the cell-insoluble fraction was similar for cells cultured with 
normal or pemphigus IgG(Fig 2). Beginning at 2 hr, however, 
there was a rapid loss of insoluble material in pemphigus IgG-
cultured cells and by 3 hr more than 70% of this preformed 
material h ad been lost. As a working hypoth esis, we believed 
this rapid solubilization was caused by proteolytic enzyme(s), 
and since the only proteins included in the mediu;n were IgG, 
the protease must have originated from the keratinocytes. We 
believed the solubilization phenomenon to be the cell suspen-
sion equivalent to acantholysis. 
A sensitive radioactive assay was devised to detect the pos-
tulated protease activity in t issue extracts and in medium from 
cell suspensions or intact epidermis [20]. Protease activity was 
demonstrated in the medium from epidermis cultured 2 days 
with pemphigus IgG, whereas the activity was not present in 
cultures containing normal lgG. The medium activity was de-
stroyed by boiling, was linear with time and protein concentra -
tion and was pH-dependent. The activity vs. pH profile for this 
protease(s) (Fig 3, lower panel) demonstrated an optimum at 
pH 6-6.5 against this substrate. Similar activity was not present 
in control culture medium or in aqueous extracts of epidermis 
cultured with either antibody (Fig 3, upper panel). Instead, the 
extracted enzymes had lower pH optima typically characteristic 
of lysosomal enzymes. 
PEMPHIGUS ACANTHOLYSIS FACTOR 
Whole human skin explants were cultured with normal or 
pemphigus IgG and examined for t he unique proteolytic en-
zyme. Although this activity could not be demonstrated in 
extracts of these cultured t issues, protease activity similar to 
that seen in cultured epidermal cell suspensions or intact epi-
dermis appeared in the medium containing pemphigus IgG, but 
not normal IgG. The activity increased linearly during t he first 
3 days in culture and the appearance of maximal activity 
coincided with the time of onset of acantholysis [21,22]. 
Because protease activity could only be demonstrated in 
cultures following interaction with t he pemphigus antibody, it 
was reasonable to suspect the enzyme had been activated or 
synthesized. We tested the possibility that pemphigus IgG could 
cause direct activation of protease activity of epidermal extracts 
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FrG 3. Protease activity vs. pH profiles of extracts or medium from 
intact epidermis which had incubated 48 hr with normal or pemphigus 
IgG (24 mg/ ml, antiepithelial antibody titer = 160). Details of the 
extraction and protease assay procedure are in reference 20. 
or epidermal homogenates, and these experiments proved to be 
negative. To evaluate the "induced synthesis" concept, the 
effects of puromycin on appearance of protease activity and 
acantholysis was studied. At lower puromycin concentrations 
(10- 7 M to 10- 5 M), appearance of protease activity was not 
prevented :md acantholysis readily occurred. At higher concen-
trations, however, enzyme activity and acantholysis were both 
inhibited. The effects of 10- 4 M puromycin on appearance of 
medium protease activity is shown in Fig 4. In cultures contain-
ing normal IgG, normal IgG + puromycin or pemphigus IgG + 
puroymcin, protease activity did not increase significantly dur-
ing a 5-day culture period and acantholysis did not develop in 
any of these 3 cultures. In contrast, cultures containing pem-
phigus IgG without puromycin showed increased enzyme activ-
ity and extensive acantholysis. Although these experiments 
provide some evidence that the protease is synthesized by the 
epidermal cell in response to the pemphigus antibody, further 
experiments to assess puromycin cytotoxicity demonstrated 
that the toxic effects of this compound could not be separated 
from the protein synthesis inhibitory effects. In addition, since 
we determined that skin killed by freezing does not generate 
enzyme activity or become acantholytic, it is uncertain whether 
these processes require specific protein synthesis or living tissue. 
The kinetic experiments suggested that protease activity and 
acantholysis were temporally related and these 2 activities 
could not be dissociated with puromycin. It is clear, however, 
that protease activity may not cause acantholysis, but may 
result from the process. In an attempt to establish a more direct 
cause and effect relationship, the conditioned medium from 
explants cultured 5 days with pemphigus IgG (which contained 
protease activity) was subjected to column chromatography to 
remove the pemphigus antibody, and the remaining material 
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Frc 4. Effects of puromycin on the appearance of protease in explant 
culture medium. Whole skin explants (30, 2 mm X 2 mm) were cultured 
with 3 ml F-10 medium which contained normal or pemphigus IgG (30 
mg/ ml, antiepithelial antibody titer = 100) in the presence or absence 
of 10- 4 M puromycin. Triplicate samples of medium were removed at 
the indicated times and assayed for protease activity (reference 22). 
Acantholysis occurred only in the culture which contained pemphigus 
IgG without puromycin. 
was tested for ability to cause acantholysis in cultw·ed fresh 
skin. Following removal of the bulk of the lgG on a standard 
DEAE cellulose column, the residual pemphigus antibody was 
removed by affinity column chromatography [21,22]. The non-
IgG material from the affinity column, when reconstituted with 
F-10 culture medium, contained enzyme activity and caused 
acantholysis in fresh skin explants. Acantholysis did not occur 
in control cultures containing the non-IgG fraction from control 
conditioned medium. Because the factor causing acantholysis 
has not been purified and shown to be the protease, we have 
referred to it as "pemphigus acantholysis factor" or P AF. 
DISCUSSION 
Extrapolation of these in vitro experiments to the patient 
allows several conclusions concerning the pathophysiology of 
pemphigus. They .provide evidence that pemphigus is truly an 
autoimmune disease in the sense that the patient's own anti-
bodies are responsible for the tissue damage, although we have 
no information that epidermal antigens are the primary mole-
cules responsible for antibody production. Possibly, the anti-
body response is directed towards unknown foreign antigens 
which possess similar determinants to the skin antigens. Since 
the pemphigus antibody causes acantholytic " lesions" in cul-
tured normal human skin (and in monkey skin) which appear 
to be identical to that in the patient, it can be concluded that 
there is nothing obviously unique about the clinically normal 
skin of the pemphigus patient. Another interesting observation 
is that the pemphigus vulgaris lesion occms in vitro, even if the 
antibody source is from patients with pemphigus foliaceous. 
These observations suggest that the clinical and histological 
features which develop in a given patient may be due to the 
response of that patient's epithelia to a similar antibody. 
These experiments have shown that pemphigus acantholysis 
occurs, at least in vitro, without participation of complement or 
inflammatory cells, thus representing a unique, if not unprece-
dented, type of immunologically-mediated tissue injury. This is 
consistent, however, with several established clinical and his-
tological observations. Pemphigus blisters usually arise on nor-
mal-appearing skin, and inflammatory infiltrates do not appear 
within the blister cavity in early lesions. Even though comple-
ment components do bind to the definitive acantholytic cells 
and complement reaction products can be found in blister fluid 
(reviewed by Jordon and Bushkell, reference 23), it is known 
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that t he pemphigus antibody does not fix complement in indi-
rect immunofluorescence tests. In addition, direct immunofluo-
rescence tests demonstrate that IgG, but not C3 is present in 
the normal-appearing skin adjacent to a blister. Since applied 
pressure on the blister will cause immediate formation of a 
lesion in this perilesional tissue (Nikolsky sign) , it is likely t hat 
the epidermal damage had already occurred due to t he binding 
of the antibody alone. 
We have proposed a mechanism to explain pemphigus acan-
tholysis which is based on these in vitro experiments. For 
discussion purposes, the process occurs in 3 sequential phases. 
In the first phase, the pemphigus antibody binds to the living 
epidermal cell. Al though it has been conventional to state that 
the binding occill·s in the "intercellular cement substance" 
(ICS), it is clear from the cell suspension studies that the site 
of binding is actually t he cell surface, and not the hypothetical 
inert "cement" substance. In the second phase the living cell 
responds to this interference by generating pemphigus acantho-
lysis factor. P AF appears to be a nonlysosomal epidermal 
protease, and it is uncertain whether it is synthesized de novo, 
or is activated by the cell in response to the antibody. In th e 
third phase, P AF actively hydrolyzes th e cell surface. Initially 
nondesmosomal cell smface areas are lost, producing intercel-
lular edema. Later the more resistant intradesmosomal contacts 
are lost, the tonofilaments retract and the cells revert to t he 
spherical acantholytic state. 
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